91 related articles for article (PubMed ID: 11027627)
1. Adenosine: A partial agonist of the growth hormone secretagogue receptor.
Smith RG; Griffin PR; Xu Y; Smith AG; Liu K; Calacay J; Feighner SD; Pong C; Leong D; Pomés A; Cheng K; Van der Ploeg LH; Howard AD; Schaeffer J; Leonard RJ
Biochem Biophys Res Commun; 2000 Oct; 276(3):1306-13. PubMed ID: 11027627
[TBL] [Abstract][Full Text] [Related]
2. Adenosine does not bind to the growth hormone secretagogue receptor type-1a (GHS-R1a).
Carreira MC; Camiña JP; Díaz-Rodríguez E; Alvear-Perez R; Llorens-Cortes C; Casanueva FF
J Endocrinol; 2006 Oct; 191(1):147-57. PubMed ID: 17065398
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone secretagogue receptor family members and ligands.
Smith RG; Leonard R; Bailey AR; Palyha O; Feighner S; Tan C; Mckee KK; Pong SS; Griffin P; Howard A
Endocrine; 2001 Feb; 14(1):9-14. PubMed ID: 11322507
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat.
Sibilia V; Muccioli G; Deghenghi R; Pagani F; De Luca V; Rapetti D; Locatelli V; Netti C
J Neuroendocrinol; 2006 Feb; 18(2):122-8. PubMed ID: 16420281
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging.
Smith RG; Sun Y; Jiang H; Albarran-Zeckler R; Timchenko N
Ann N Y Acad Sci; 2007 Nov; 1119():147-64. PubMed ID: 18056963
[TBL] [Abstract][Full Text] [Related]
6. Structure and regulation of the growth hormone secretagogue receptor.
Petersenn S
Minerva Endocrinol; 2002 Dec; 27(4):243-56. PubMed ID: 12511847
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors.
McKee KK; Palyha OC; Feighner SD; Hreniuk DL; Tan CP; Phillips MS; Smith RG; Van der Ploeg LH; Howard AD
Mol Endocrinol; 1997 Apr; 11(4):415-23. PubMed ID: 9092793
[TBL] [Abstract][Full Text] [Related]
8. Characterization of ghrelin receptor activity in a rat pituitary cell line RC-4B/C.
Falls HD; Dayton BD; Fry DG; Ogiela CA; Schaefer VG; Brodjian S; Reilly RM; Collins CA; Kaszubska W
J Mol Endocrinol; 2006 Aug; 37(1):51-62. PubMed ID: 16901923
[TBL] [Abstract][Full Text] [Related]
9. Adenosine is an agonist of the growth hormone secretagogue receptor.
Tullin S; Hansen BS; Ankersen M; Møller J; Von Cappelen KA; Thim L
Endocrinology; 2000 Sep; 141(9):3397-402. PubMed ID: 10965912
[TBL] [Abstract][Full Text] [Related]
10. Solubilization and characterization of a growth hormone secretagogue receptor from porcine anterior pituitary membranes.
Pomés A; Pong SS; Schaeffer JM
Biochem Biophys Res Commun; 1996 Aug; 225(3):939-45. PubMed ID: 8780714
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin, an endogenous ligand for the growth hormone-secretagogue receptor, is expressed in the human adrenal cortex.
Tortorella C; Macchi C; Spinazzi R; Malendowicz LK; Trejter M; Nussdorfer GG
Int J Mol Med; 2003 Aug; 12(2):213-7. PubMed ID: 12851720
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone releasing substances: types and their receptors.
Smith RG; Palyha OC; Feighner SD; Tan CP; McKee KK; Hreniuk DL; Yang L; Morriello G; Nargund R; Patchett AA; Howard AD
Horm Res; 1999; 51 Suppl 3():1-8. PubMed ID: 10592437
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor.
Muccioli G; Pons N; Ghè C; Catapano F; Granata R; Ghigo E
Eur J Pharmacol; 2004 Sep; 498(1-3):27-35. PubMed ID: 15363972
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin, cortistatin, ghrelin and glucose metabolism.
Gauna C; van der Lely AJ
J Endocrinol Invest; 2005; 28(11 Suppl International):127-31. PubMed ID: 16625861
[TBL] [Abstract][Full Text] [Related]
15. Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues.
Feighner SD; Howard AD; Prendergast K; Palyha OC; Hreniuk DL; Nargund R; Underwood D; Tata JR; Dean DC; Tan CP; McKee KK; Woods JW; Patchett AA; Smith RG; Van der Ploeg LH
Mol Endocrinol; 1998 Jan; 12(1):137-45. PubMed ID: 9440817
[TBL] [Abstract][Full Text] [Related]
16. Cortistatin mimics somatostatin by inducing a dual, dose-dependent stimulatory and inhibitory effect on growth hormone secretion in somatotropes.
Luque RM; Peinado JR; Gracia-Navarro F; Broglio F; Ghigo E; Kineman RD; Malagón MM; Castaño JP
J Mol Endocrinol; 2006 Jun; 36(3):547-56. PubMed ID: 16720722
[TBL] [Abstract][Full Text] [Related]
17. Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R).
Gauna C; van de Zande B; van Kerkwijk A; Themmen AP; van der Lely AJ; Delhanty PJ
Mol Cell Endocrinol; 2007 Aug; 274(1-2):30-4. PubMed ID: 17601657
[TBL] [Abstract][Full Text] [Related]
18. Adenosine is not a direct GHSR agonist--artificial cross-talk between GHSR and adenosine receptor pathways.
Hermansson NO; Morgan DG; Drmota T; Larsson N
Acta Physiol (Oxf); 2007 May; 190(1):77-86. PubMed ID: 17428235
[TBL] [Abstract][Full Text] [Related]
19. Evidence against adenosine analogues being agonists at the growth hormone secretagogue receptor.
Johansson S; Fredholm BB; Hjort C; Morein T; Kull B; Hu PS
Biochem Pharmacol; 2005 Aug; 70(4):598-605. PubMed ID: 15979585
[TBL] [Abstract][Full Text] [Related]
20. Ligand activation domain of human orphan growth hormone (GH) secretagogue receptor (GHS-R) conserved from Pufferfish to humans.
Palyha OC; Feighner SD; Tan CP; McKee KK; Hreniuk DL; Gao YD; Schleim KD; Yang L; Morriello GJ; Nargund R; Patchett AA; Howard AD; Smith RG
Mol Endocrinol; 2000 Jan; 14(1):160-9. PubMed ID: 10628755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
